Works matching IS 00070920 AND DT 2023 AND VI 128 AND IP 2
Results: 25
Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction to: The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Thinking inside the box: intracellular roles for complement system proteins come into focus.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 2, p. 165, doi. 10.1038/s41416-022-02116-7
- By:
- Publication type:
- Article
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 2, p. 161, doi. 10.1038/s41416-022-02107-8
- By:
- Publication type:
- Article
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
- Published in:
- 2023
- By:
- Publication type:
- corrected article
Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Clinical significance and functional role of adhesion G-protein-coupled receptors in human pancreatic ductal adenocarcinoma.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Th2 cells inhibit growth of colon and pancreas cancers by promoting anti-tumorigenic responses from macrophages and eosinophils.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Intratumoral heterogeneity affects tumor regression and Ki67 proliferation index in perioperatively treated gastric carcinoma.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Associations between serum glucose, insulin, insulin resistance and the risk of incident primary liver cancer or chronic liver disease mortality: a nested case–control study.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 2, p. 275, doi. 10.1038/s41416-022-02042-8
- By:
- Publication type:
- Article
The tumour-associated stroma correlates with poor clinical outcomes and immunoevasive contexture in patients with upper tract urothelial carcinoma: results from a multicenter real-world study (TSU-01 Study).
- Published in:
- 2023
- By:
- Publication type:
- journal article
Capecitabine induces hand-foot syndrome through elevated thymidine phosphorylase-mediated locoregional toxicity and GSDME-driven pyroptosis that can be relieved by tipiracil.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Association between angiotensin-converting enzyme inhibitors and the risk of lung cancer: a systematic review and meta-analysis.
- Published in:
- 2023
- By:
- Publication type:
- journal article
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer.
- Published in:
- 2023
- By:
- Publication type:
- journal article
The application of single-cell sequencing in pancreatic neoplasm: analysis, diagnosis and treatment.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 2, p. 206, doi. 10.1038/s41416-022-02023-x
- By:
- Publication type:
- Article
Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 2, p. 255, doi. 10.1038/s41416-022-02022-y
- By:
- Publication type:
- Article
The utility of ctDNA in detecting minimal residual disease following curative surgery in colorectal cancer: a systematic review and meta-analysis.
- Published in:
- 2023
- By:
- Publication type:
- journal article
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 2, p. 190, doi. 10.1038/s41416-022-01998-x
- By:
- Publication type:
- Article
Prostate cancer in transgender women: considerations for screening, diagnosis and management.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 2, p. 177, doi. 10.1038/s41416-022-01989-y
- By:
- Publication type:
- Article